Frontlight ResearchEarly access
Trial site
Victoria Cardiac Arrhythmia Trials, Inc.
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation4 trials
- Stroke2 trials
- Phase
- Phase 42 trials
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Ottawa Heart Institute Research Corporation2 trials
- Hamilton Health Sciences Corporation1 trial
- Janssen Research & Development, LLC1 trial
- Population Health Research Institute1 trial
Running trials
Recruiting
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026